North America Chemiluminescence Immunoassay Market Size & Outlook

The chemiluminescence immunoassay market in North America is expected to reach a projected revenue of US$ 5,210.8 million by 2028. A compound annual growth rate of 7.2% is expected of North America chemiluminescence immunoassay market from 2021 to 2028.

Revenue, 2020 (US$M)
$2,981.0
Forecast, 2028 (US$M)
$5,210.8
CAGR, 2021 - 2028
7.2%
Report Coverage
North America

North America chemiluminescence immunoassay market highlights

  • The North America chemiluminescence immunoassay market generated a revenue of USD 2,981.0 million in 2020.
  • The market is expected to grow at a CAGR of 7.2% from 2021 to 2028.
  • In terms of segment, consumables was the largest revenue generating product & services in 2020.
  • Consumables is the most lucrative product & services segment registering the fastest growth during the forecast period.
  • Country-wise, Canada is expected to register the highest CAGR from 2021 to 2028.


North America data book summary

Market revenue in 2020USD 2,981.0 million
Market revenue in 2028USD 5,210.8 million
Growth rate7.2% (CAGR from 2020 to 2028)
Largest segmentConsumables
Fastest growing segmentConsumables
Historical data covered2016 - 2019
Base year for estimation2020
Forecast period covered2021 - 2028
Quantitative unitsRevenue in USD million
Market segmentationConsumables, Instruments, Software & Services
Key market players worldwideDiasorin SpA, Abbott Laboratories, Siemens Healthineers AG ADR, QuidelOrtho Corp, shenzhen mindray automation equipment co., Immunodiagnostic Systems, Beckman Coulter, Roche Holding AG ADR, Roche, Inova Diagnostics, Maccura


Other key industry trends

  • In terms of revenue, North America region accounted for 40.6% of the global chemiluminescence immunoassay market in 2020.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2028.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 3,286.0 million by 2028.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Chemiluminescence Immunoassay Market Scope

Chemiluminescence immunoassay market segmentation & scope
Consumables
Automated
Semi Automated
Software & Services
Therapeutic Drug Monitoring
Oncology
Cardiology
Endocrinology
Infectious Disease testing
Autoimmune Disease
Others
Hospitals
Clinical laboratories
Pharmaceutical & biotechnology companies
Others ( Research Institutes, Clinics, CRO)

Chemiluminescence Immunoassay Market Companies

Name Profile # Employees HQ Website

North America chemiluminescence immunoassay market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to chemiluminescence immunoassay market will help companies and investors design strategic landscapes.


Consumables was the largest segment with a revenue share of 65.65% in 2020. Horizon Databook has segmented the North America chemiluminescence immunoassay market based on consumables, instruments, software & services covering the revenue growth of each sub-segment from 2016 to 2028.


North America dominated the global market in 2020, which can be attributed to rise in the demand for diagnostics due to increase in the incidence of chronic diseases and easy availability of technologically advanced diagnostic techniques.

In addition, high incidence of infectious diseases in the region, such as COVID-19, HIV, tuberculosis, and influenza, is boosting the demand for detection & treatment. Furthermore, well-established healthcare infrastructure and availability of government funding for research are anticipated to augment growth of the market in this region.

In July 2020, NIH invested USD 248.7 million in the development of new technologies in order to address challenges that are associated with testing of COVID-19. NIH’s Rapid Acceleration of Diagnostics (RADx) initiative awarded contracts to seven biomedical diagnostic companies in order to support development of COVID-19 POC and lab-based tests and increase their availability.

Reasons to subscribe to North America chemiluminescence immunoassay market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of North America chemiluminescence immunoassay market databook

  • Our clientele includes a mix of chemiluminescence immunoassay market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the North America chemiluminescence immunoassay market , including forecasts for subscribers. This continent databook contains high-level insights into North America chemiluminescence immunoassay market from 2016 to 2028, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

North America chemiluminescence immunoassay market size, by country, 2016-2028 (US$M)

North America Chemiluminescence Immunoassay Market Outlook Share, 2020 & 2028 (US$M)

North America chemiluminescence immunoassay market size, by country, 2016-2028 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more